While early studies show good results, larger and more standardized clinical trials are still needed to fully understand its long-term benefits and the best treatment settings for different types of patients
Publisher's note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
The new programs starting dose is 25% of the lowest starting dose in Nooms other GLP-1 offerings
No difference between smokers and nonsmokers regarding supplemental and dietary intakes of antioxidant micronutrients, including selenium, was found to contribute to the association of smoking and rectal cancer (68)
As Big Tech companies like Amazon expand deeper into healthcare, and as venture capital and private equity increasingly back telehealth platforms acquiring or partnering with compounding pharmacies, the power dynamics are starting to evolve